Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems

Launched by SOCIETE DETUDE, DE RECHERCHE ET DE FABRICATION · Oct 17, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the use of a specific type of hip implant called the SAGITTA EVL R revision femoral stem, which is used for patients with hip arthropathy (a condition affecting the hip joint). Researchers want to understand how well this implant works and how safe it is by collecting information from patients who have received it. The study aims to ensure that the implant meets current safety and performance standards.

To participate in this study, you need to be at least 18 years old and have received the SAGITTA EVL R revision femoral stem between January 1, 2016, and December 31, 2018. You also need to be part of the French health insurance system. If you decide to join, you'll be asked for your consent to collect information about your experience with the implant and to follow up on your recovery after surgery. It's important that you understand the surgeon's instructions and can attend any necessary follow-up appointments. This study is currently looking for participants, and anyone who meets the criteria could help contribute to important information about hip replacement surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient over 18 years old at the time of surgery,
• • Patient implanted with a SAGITTA EVL R revision femoral stem within its indications between 01/01/2016 and 31/12/2018,
• • Affiliated to French health insurance system
• Exclusion Criteria:
• • Patient who has not expressed consent for data collection and participation in the study,
• • Patient unable to understand the surgeon's instructions or to perform postoperative follow-up.
• • Patient with a contraindication to the use of the SAGITTA EVL R revision femoral stem
• • Patient implanted with a SAGITTA EVL R revision femoral stem outside its indication